Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal CO2 for TMD Pain
NCT00484029Phase 2Completed
- Sponsor
- Capnia, Inc.
- Start
- Feb 2007
- Primary completion
- Oct 2008
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of Carbon dioxide in temporomandibular disorders (TMD), sponsored by Capnia, Inc.. Started Feb 2007; status: completed.
02
Drugs
Carbon dioxide
03
Conditions
temporomandibular disorders (TMD)
Beyond the preview
Go deeper on NCT00484029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00484029.